Featured Research

from universities, journals, and other organizations

New method fixes broken proteins to treat genetic diseases

Date:
January 16, 2010
Source:
Fox Chase Cancer Center
Summary:
Researchers have demonstrated how it could be possible to treat genetic diseases by enhancing the natural ability of cells to restore their own mutant proteins. In particular, they found that drugs called proteosome inhibitors could provide one way of manipulating cells into producing more of a so-called chaperone protein, named Hsp70, which helps amino acid chains fold into their proper protein form.

Researchers at Fox Chase Cancer Center have demonstrated how it could be possible to treat genetic diseases by enhancing the natural ability of cells to restore their own mutant proteins. In particular, they found that drugs called proteosome inhibitors could provide one way of manipulating cells into producing more of a so-called chaperone protein, named Hsp70, which helps amino acid chains fold into their proper protein form.

Their latest findings, presented in the journal PLoS Genetics, expand their previous research from yeast models of disease to human cell cultures and animal models. According to the researchers, if this approach works in humans, it could be a way to turn certain debilitating -- or even fatal -- genetic diseases into more treatable, chronic conditions.

"Hsp70 pulls misfolded mutant proteins apart like a twisted rubber bands and allows them to snap back into place, eventually a significant percentage of these proteins will snap back into something approaching a functional shape," says the study's leader, Warren Kruger, Ph.D., professor in Fox Chase's Cancer Biology program. "If this can be done in humans, it could represent a way of reducing the severity -- or perhaps correcting -- certain hereditary diseases, even some familial cancers."

Genetic diseases are often caused by a specific type of genetic alteration called a missense mutation that makes cells add an incorrect amino acid into the protein chain. Since the shape of a protein depends on the specific arrangement of amino acids, even a single error amid a gene's very long stretch of DNA can cause the gene's protein product to become misshapen. Kruger and his colleagues studied ways to reverse the functional effects of missense mutationsfor three genetic diseases: two severe inherited metabolic disorders (CBS deficiency and MTHFR deficiency) and one inherited cancer syndrome (Li-Fraumeini).

In each case, the Fox Chase researchers found that it was possible to restore the function of the mutant proteins by tricking the cell into increasing levels of Hsp70. "We have shown that the more opportunities we give Hsp70 proteins to try to 'fix' mutants, the more likely it is that they will succeed," Kruger says.

While this approach has yet to be applied to clinical medicine, there are several drugs that are known to induce Hsp70 in humans. Kruger found that treating yeast and mammalian cells with a drug called bortezomib elevated the amount of available Hsp70 and rescued mutant proteins. Bortezomib is a member of a class of drugs called proteasome inhibitors, which decreases the effectiveness of enzymes that cells use to dispose of non-functioning proteins. Bortezemib (known under the brand name Velcade) is currently used to treat patients with multiple myeloma.

"We found that bortezomib can stabilize and restore mutants by tripling the amount of available Hsp70," Kruger says. "While we do not yet know the entiremechanism, we do know that bortezomib doesn't rescue mutants in cells that lack the gene for Hsp70."

Kruger and his colleagues are currently studying how to best adapt these findings to human disease.

"Of course, the big question we need to answer is one of safety -- what are the long term effects of sustained Hsp70 elevation?" Kruger says. "The answer may be very disease-specific, one of how many mutant proteins must be restored to reduce the severity of a given genetic disease."

Funding for this research comes from grants from the National Institutes of Health and the Commonwealth of Pennsylvania.


Story Source:

The above story is based on materials provided by Fox Chase Cancer Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Laishram R. Singh, Sapna Gupta, Nicholaas H. Honig, Jan P. Kraus, Warren D. Kruger. Activation of Mutant Enzyme Function In Vivo by Proteasome Inhibitors and Treatments that Induce Hsp70. PLoS Genetics, 2010; 6 (1): e1000807 DOI: 10.1371/journal.pgen.1000807

Cite This Page:

Fox Chase Cancer Center. "New method fixes broken proteins to treat genetic diseases." ScienceDaily. ScienceDaily, 16 January 2010. <www.sciencedaily.com/releases/2010/01/100115094105.htm>.
Fox Chase Cancer Center. (2010, January 16). New method fixes broken proteins to treat genetic diseases. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2010/01/100115094105.htm
Fox Chase Cancer Center. "New method fixes broken proteins to treat genetic diseases." ScienceDaily. www.sciencedaily.com/releases/2010/01/100115094105.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins